In 2022, the Chinese pharmaceutical firm Innovent Biologics Inc. spent more than 2.8 billion yuan on research and development projects, representing a growth of more than 500 million yuan from the previous year. The core products of Innovent Biologics include anti-tumor medicines and drugs treating metabolic disorders and autoimmune diseases.
Research and development spendings of Innovent Biologics Inc. from 2019 to 2022
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Innovent Biologics. (March 28, 2023). Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. "Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan)." Chart. March 28, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. (2023). Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. "Research and Development Spendings of Innovent Biologics Inc. from 2019 to 2022 (in Billion Yuan)." Statista, Statista Inc., 28 Mar 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics, Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/ (last visited November 10, 2024)
Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph], Innovent Biologics, March 28, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
